Skip to main content

SGX943 FDA Approval Status

FDA Approved: No
Brand name: SGX943
Generic name: dusquetide
Company: Soligenix, Inc.
Treatment for: Melioidosis

SGX943 (dusquetide) is an Innate Defense Regulator (IDR) in development for the treatment of melioidosis.

Development timeline for SGX943

May 31, 2016FDA Grants Soligenix “Fast Track” Designation for SGX943 for the Treatment of Melioidosis

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.